These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19696445)
1. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445 [TBL] [Abstract][Full Text] [Related]
2. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350 [TBL] [Abstract][Full Text] [Related]
3. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925 [TBL] [Abstract][Full Text] [Related]
4. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647 [TBL] [Abstract][Full Text] [Related]
5. Wnt5A activates the calpain-mediated cleavage of filamin A. O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143 [TBL] [Abstract][Full Text] [Related]
6. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008 [TBL] [Abstract][Full Text] [Related]
7. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864 [TBL] [Abstract][Full Text] [Related]
8. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740 [TBL] [Abstract][Full Text] [Related]
9. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020 [TBL] [Abstract][Full Text] [Related]
10. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340 [TBL] [Abstract][Full Text] [Related]
11. WNT5A expression increases during melanoma progression and correlates with outcome. Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093 [TBL] [Abstract][Full Text] [Related]
12. A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis. O'Connell MP; Weeraratna AT Pigment Cell Melanoma Res; 2011 Dec; 24(6):1133-47. PubMed ID: 21978367 [TBL] [Abstract][Full Text] [Related]
13. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Webster MR; Xu M; Kinzler KA; Kaur A; Appleton J; O'Connell MP; Marchbank K; Valiga A; Dang VM; Perego M; Zhang G; Slipicevic A; Keeney F; Lehrmann E; Wood W; Becker KG; Kossenkov AV; Frederick DT; Flaherty KT; Xu X; Herlyn M; Murphy ME; Weeraratna AT Pigment Cell Melanoma Res; 2015 Mar; 28(2):184-95. PubMed ID: 25407936 [TBL] [Abstract][Full Text] [Related]
14. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. Ekström EJ; Sherwood V; Andersson T PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614 [TBL] [Abstract][Full Text] [Related]
15. Syndecans reside in sphingomyelin-enriched low-density fractions of the plasma membrane isolated from a parathyroid cell line. Podyma-Inoue KA; Hara-Yokoyama M; Shinomura T; Kimura T; Yanagishita M PLoS One; 2012; 7(3):e32351. PubMed ID: 22396758 [TBL] [Abstract][Full Text] [Related]
16. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed. Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion. Linnskog R; Mohapatra P; Moradi F; Prasad CP; Andersson T Oncotarget; 2016 Jun; 7(25):37790-37802. PubMed ID: 27191257 [TBL] [Abstract][Full Text] [Related]
18. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells. Lim HC; Multhaupt HA; Couchman JR Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282 [TBL] [Abstract][Full Text] [Related]
19. Assaying Wnt5A-mediated invasion in melanoma cells. O'Connell MP; French AD; Leotlela PD; Weeraratna AT Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260 [TBL] [Abstract][Full Text] [Related]
20. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]